We are live on ! Find out more
RGNX icon

Regenxbio

177 hedge funds and large institutions have $1.87B invested in Regenxbio in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

252% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 23

180% more capital invested

Capital invested by funds: $668M → $1.87B (+$1.2B)

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

55% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 33

48% more funds holding

Funds holding: 120177 (+57)

44% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $10.6M

10.83% more ownership

Funds ownership: 70.66%81.49% (+11%)

Holders
177
Holders Change
+57
Holders Change %
+47.5%
% of All Funds
4.05%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
81
Increased
51
Reduced
33
Closed
23
Calls
$15.3M
Puts
$10.6M
Net Calls
+$4.7M
Net Calls Change
+$3.73M
Name Holding Trade Value Shares
Change
Change in
Stake
SEI Investments
101
SEI Investments
Pennsylvania
$899K +$598K +12,518 +139,089%
UBS AM
102
UBS AM
Illinois
$870K +$579K +12,123 New
LSERS
103
Louisiana State Employees Retirement System
Louisiana
$861K +$573K +12,000 New
MSL
104
Mackay Shields LLC
New York
$825K +$549K +11,500 New
New York State Teachers Retirement System (NYSTRS)
105
New York State Teachers Retirement System (NYSTRS)
New York
$817K +$544K +11,386 New
TAM
106
Tocqueville Asset Management
New York
$766K +$510K +10,675 New
MSFP
107
Mark Sheptoff Financial Planning
Connecticut
$753K +$501K +10,500 New
Two Sigma Advisers
108
Two Sigma Advisers
New York
$725K -$401K -8,400 -45%
ARTA
109
A.R.T. Advisors
New York
$722K -$2.41M -50,495 -83%
AIM
110
Alambic Investment Management
California
$721K +$480K +10,050 New
Nomura Asset Management
111
Nomura Asset Management
Japan
$718K
SGA
112
Sector Gamma AS
Norway
$718K +$478K +10,000 New
BCA
113
Bay Colony Advisors
Massachusetts
$696K +$463K +9,700 New
PCM
114
Prelude Capital Management
New York
$669K +$46.1K +965 +12%
MLICM
115
Metropolitan Life Insurance Company (MetLife)
New York
$665K
SOADOR
116
State of Alaska Department of Revenue
Alaska
$629K +$419K +8,770 New
MSA
117
Mason Street Advisors
Wisconsin
$556K +$370K +7,747 New
MERSOM
118
Municipal Employees' Retirement System of Michigan
Michigan
$542K +$361K +7,560 New
PNC Financial Services Group
119
PNC Financial Services Group
Pennsylvania
$491K +$327K +6,851 New
Squarepoint
120
Squarepoint
New York
$483K -$926K -19,384 -74%
PIA
121
Piedmont Investment Advisors
North Carolina
$451K +$300K +6,281 New
ECM
122
Element Capital Management
New York
$424K -$167K -3,491 -37%
PA
123
Profund Advisors
Maryland
$422K +$281K +5,886 New
Los Angeles Capital Management
124
Los Angeles Capital Management
California
$420K +$279K +5,847 New
II
125
Ibex Investors
Colorado
$417K -$207K -4,340 -43%

RGNX Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2018, worth a combined $1.87B — up 180% from $668M a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new RGNX positions and 23 closed out — a net gain of 58 holders — while 51 added to existing stakes and 33 trimmed.

The largest buyer was BlackRock, adding an estimated $95.4M. The largest seller was Citadel Advisors, cutting an estimated $35.6M.

  • 177 institutional investors held Regenxbio (RGNX) as of Q2 2018, up from 120 in Q1 2018.
  • Funds reported $1.87B of Regenxbio stock for Q2 2018, up 180% quarter-over-quarter.
  • 81 funds opened new Regenxbio positions in Q2 2018 and 23 closed out, a net change of +58 holders.
  • The largest Regenxbio buyer in Q2 2018 was BlackRock, an estimated $95.4M added.
  • The largest Regenxbio seller in Q2 2018 was Citadel Advisors, an estimated $35.6M sold.

Based on aggregated 13F filings for Q2 2018.